TiGenix NV

Datum

26/04/2018

Categorie

ProspectusOPA

Sector

OPA

Files

2018-(123)-EN-OPA20171230-A14-B01-C01-NP-CD26_04.PDF

Filter

OPA

Verrichting

Vrijwillige openbare overnameaanbieding

Effecten

Aandelen

Document

Prospectus

LEI

549300U4XEIPPXHC2L05

Company

Company	Company Type
Takeda Pharmaceutical Company	Bieder
TiGenix NV	Doelvenootschap OBA